Definitive Contract 36C10X22C0006

Award Date 4/18/22
Potential Completion Date 2/27/23
Potential Value $146M
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chambersburg, PA 17201, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

This is a definitive contract awarded by the Department of Veterans Affairs (VA) Strategic Acquisition Center Frederick to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $146,265,755.00 contract is for the delivery of COVID-19 and flu test kits and swabs, with a completion date of February 27, 2023. The contract is a firm fixed-price arrangement with no set-aside designation.

Cepheid is a long-standing federal contractor, having received multiple prime contracts, indefinite delivery vehicles (IDVs), and subcontracts from various agencies including the VA, Defense Logistics Agency, and Department of Health and Human Services. Cepheid's GeneXpert diagnostic systems and associated reagents, test kits, and consumables are used extensively by the VA and other agencies to support clinical testing programs. This contract award reflects the VA's continued reliance on Cepheid's molecular diagnostic solutions to meet the evolving testing needs of the veteran population.

Generated 9/7/24, 11:49 AM